Provided by Tiger Trade Technology Pte. Ltd.

Ultragenyx Pharmaceutical

20.18
-0.3400-1.66%
Post-market: 20.450.2700+1.34%19:49 EST
Volume:3.15M
Turnover:63.86M
Market Cap:1.95B
PE:-3.46
High:20.89
Open:20.65
Low:19.78
Close:20.52
52wk High:46.27
52wk Low:18.41
Shares:96.48M
Float Shares:92.79M
Volume Ratio:1.17
T/O Rate:3.40%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-5.8316
EPS(LYR):-5.8316
ROE:-412.99%
ROA:-24.92%
PB:212.57
PE(LYR):-3.46

Loading ...

Ultragenyx Faces Securities Class Action After Stock Plunge

Reuters
·
7 hours ago

Wedbush Reaffirms Their Hold Rating on Ultragenyx Pharmaceutical (RARE)

TIPRANKS
·
Yesterday

Ultragenyx price target lowered to $37 from $39 at Evercore ISI

TIPRANKS
·
Yesterday

Ultragenyx Pharma Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Yesterday

Ultragenyx price target lowered to $50 from $60 at H.C. Wainwright

TIPRANKS
·
Yesterday

Ultragenyx Faces Securities Class Action Over Misleading Study Claims

Reuters
·
Feb 16

Is Ultragenyx Pharmaceutical (RARE) Mispriced After Steep Multi‑Year Share Price Declines?

Simply Wall St.
·
Feb 16

Ultragenyx Faces Securities Class Action Over Alleged Misleading Statements

Reuters
·
Feb 15

Ultragenyx Faces Class Action Lawsuit Over Alleged Misleading Statements on Setrusumab Trials

Reuters
·
Feb 14

Why Is Ultragenyx Stock Sinking Friday?

Benzinga
·
Feb 14

Ultragenyx Pharmaceutical Faces Lawsuit Following Clinical Trial Disclosures

TIPRANKS
·
Feb 14

Analysts Offer Insights on Healthcare Companies: Baxter International (BAX) and Ultragenyx Pharmaceutical (RARE)

TIPRANKS
·
Feb 13

Ultragenyx price target lowered to $61 from $71 at Goldman Sachs

TIPRANKS
·
Feb 13

Stock Track | Ultragenyx Pharmaceutical Plummets 8.34% Intraday Following Multiple Analyst Price Target Cuts

Stock Track
·
Feb 13

Stock Track | Ultragenyx Pharmaceutical Plunges 7.28% in Pre-market After Multiple Analyst Price Target Cuts

Stock Track
·
Feb 13

Ultragenyx Pharmaceutical Inc : TD Cowen Cuts Target Price to $49 From $75

THOMSON REUTERS
·
Feb 13

RBC Capital Reaffirms Their Buy Rating on Ultragenyx Pharmaceutical (RARE)

TIPRANKS
·
Feb 13

Truist Cuts Price Target on Ultragenyx Pharmaceutical to $76 From $90, Keeps Buy Rating

MT Newswires Live
·
Feb 13

Ultragenyx Pharmaceutical Inc : Leerink Partners Cuts Target Price to $60 From $70

THOMSON REUTERS
·
Feb 13

Stock Track | Ultragenyx Pharmaceutical Plunges 5.32% After-Hours on Earnings Miss, Weak Guidance and Restructuring Plan

Stock Track
·
Feb 13